Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Change in Acquisitions & Divestments (2017 - 2025)

Protagonist Therapeutics (PTGX) has disclosed Change in Acquisitions & Divestments for 9 consecutive years, with $3000.0 as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments fell 100.0% to $3000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.0 million through Dec 2025, down 97.84% year-over-year, with the annual reading at $7.0 million for FY2025, 97.84% down from the prior year.
  • Change in Acquisitions & Divestments hit $3000.0 in Q4 2025 for Protagonist Therapeutics, up from -$3000.0 in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $106.0 million in Q4 2024 to a low of -$3000.0 in Q2 2025.
  • Historically, Change in Acquisitions & Divestments has averaged $55.9 million across 5 years, with a median of $58.7 million in 2024.
  • Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 188.81% in 2024 and later tumbled 100.0% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $58.8 million in 2021, then skyrocketed by 44.0% to $84.6 million in 2022, then tumbled by 56.62% to $36.7 million in 2023, then surged by 188.81% to $106.0 million in 2024, then tumbled by 100.0% to $3000.0 in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for PTGX at $3000.0 in Q4 2025, -$3000.0 in Q2 2025, and $7.0 million in Q1 2025.